The bear market has weighed on stocks across industries this year. Even some of the world's strongest companies have seen their shares decline in the double digits. But two biotech companies have defied today's difficult market.

Biogen (NASDAQ: BIIB) and Vertex Pharmaceuticals (NASDAQ: VRTX) have both climbed in the double digits -- and for good reason. Both companies may be set to launch exciting new products in the not-too-distant future. Which one of these top stocks represents the better bear market buy right now? Motley Fool contributors Adria Cimino and Keith Speights offer some answers.

Adria Cimino (Biogen): This year started out rocky for Biogen. The company watched its big dreams for its Alzheimer's disease drug, Aduhelm, disappear. The controversial treatment never gained support in the medical community. Biogen ended up dismantling the Aduhelm commercial infrastructure.

Continue reading

Source Fool.com